Atea Pharmaceuticals (AVIR) Cash from Financing Activities (2020 - 2026)
Atea Pharmaceuticals' Cash from Financing Activities came in at $257,000 for Q1 2026, compared with -$347,000 a year earlier.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Cash from Financing Activities (2020 - 2026) Analysis & Trends
For FY2025, Atea Pharmaceuticals' Cash from Financing Activities was -$25.75 million.
- Going back by year, Cash from Financing Activities was $267,000 in FY2024 (+3.9%), $257,000 in FY2023 (-30.5%), $370,000 in FY2022 (-74.7%) and $1.47 million in FY2021 (-99.7%).
- The Q1 2026 figure represents the highest quarterly Cash from Financing Activities since Q3 2021.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q3 2024 (growth of 27.2%), and the weakest in Q4 2021 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Atea Pharmaceuticals | 417.87 Mn | 417.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 257,000.00 |
| Sep 30, 2025 | -11.31 Mn |
| Jun 30, 2025 | -14.09 Mn |
| Mar 31, 2025 | -347,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Mar 31, 2023 | 165,000.00 |
| Sep 30, 2022 | 147,000.00 |
| Mar 31, 2022 | 223,000.00 |
| Dec 31, 2021 | 142,000.00 |
| Sep 30, 2021 | 795,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 471,000.00 |
| Dec 31, 2020 | 426.22 Mn |
| Sep 30, 2020 | -913,000.00 |
| Jun 30, 2020 | 106.45 Mn |
| Mar 31, 2020 | -6,000.00 |
API Access
Atea Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();